| Catalogue No. |
R-1466-100 |
| Description |
Cardiac Fatty Acid Binding Protein (FABP3) is thought to have a role in the intracellular transport of long-chain fatty acids and their acyl-CoA esters (Ref: SWISSPROT). |
| Batch No. |
See product label |
| Unit size |
100 ug |
| Antigen |
A synthetic peptide corresponding to a region (119-133 aa) from the C-terminus of human Cardiac Fatty Acid Binding Protein (FABP3). |
| Antigen Location |
119-133 |
| Other Names |
Fatty acid-binding protein; heart; Fatty acid-binding protein 3; Heart-type fatty acid-binding protein; H-FABP; Mammary-derived growth inhibitor; MDGI; Muscle fatty acid-binding protein; M-FABP; FABP3; FABP11; MDGI; |
| Accession |
P05413 FABPH_HUMAN; |
| Produced in |
Rabbit |
| Applications |
Western Blotting (WB) and Immunohistochemistry (IHC). A concentration of 1.0 ug/mL is recommended for WB. Human FABP3 (precursor) has a predicted length of 133 amino acids and MW of 15 kDa. A concentration of 1.0 ug/mL is recommended for IHC to detect the protein in formalin fixed and paraffin embedded tissues. Heat mediated antigen retrieval is required. A concentration of 1.0 ug/mL is also recommended for IHC in frozen tissue. Biosensis recommends optimal dilutions/concentrations should be determined by the end user. |
| Specificity |
The specificity of this antibody has been confirmed by WB and IHC against the antigen. |
| Antibody Against |
Cardiac Fatty Acid Binding Protein |
| Cross-reactivity |
Human; rat; mouse; |
| Blast URL |
Click here |
| Form |
Lyophilised with 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3 |
| Appearance |
White powder |
| Reconstitution |
Reconstitute in 100 uL of sterile distilled water to achieve an antibody concentration of 1 mg/mL. Centrifuge to remove any insoluble material. |
| Storage |
At least 12 months after purchase at 2-8C (lyophilized formulations). After reconstitution, aliquot and store at -20C for a higher stability. Avoid freeze-thaw cycles. |
| Expiry Date |
12 months after purchase |
